Opi D.H.Longley R.J.Takashima E.Spelman T.Tayipto Y.Schoffer K.Brewster J.Reiling L.Wines B.D.Kiniboro B.Siba P.Harbers M.Hogarth M.Tsuboi T.Robinson L.J.Mueller I.Beeson J.G.Mahidol University2026-03-312026-03-312026-03-10Immunity Vol.59 No.3 (2026) , 783-797.e410747613https://repository.li.mahidol.ac.th/handle/123456789/115892Understanding immunity against Plasmodium vivax, a leading cause of malaria, will accelerate development of vaccines, which are currently lagging. Opi et al. identify important mechanisms and target antigens of protective P. vivax immunity in children, including combinations of responses that afford greater protection, revealing pathways for vaccine development.MedicineImmunology and MicrobiologyArticleSCOPUS10.1016/j.immuni.2026.02.0032-s2.0-1050333659731097418041759513